{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T22:07:33Z","timestamp":1789596453156,"version":"build-2803163510"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2016,9,1]],"date-time":"2016-09-01T00:00:00Z","timestamp":1472688000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2016,9,1]],"date-time":"2016-09-01T00:00:00Z","timestamp":1472688000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Podocyte injury and the appearance of proteinuria are features of minimal-change disease (MCD). Cyclosporin A (CsA) and tacrolimus (FK506) has been reported to reduce proteinuria in patients with nephrotic syndrome, but mechanisms remain unknown. We, therefore, investigated the protective mechanisms of CsA and FK506 on proteinuria in a rat model of MCD induced by puromycin aminonucleoside (PAN) and <jats:italic>in vitro<\/jats:italic> cultured mouse podocytes. Our results showed that CsA and FK506 treatment decreased proteinuria via a mechanism associated to a reduction in the foot-process fusion and desmin, and a recovery of synaptopodin and podocin. In PAN-treated mouse podocytes, pre-incubation with CsA and FK506 restored the distribution of the actin cytoskeleton, increased the expression of synaptopodin and podocin, improved podocyte viability, and reduced the migrating activities of podocytes. Treatment with CsA and FK506 also inhibited PAN-induced podocytes apoptosis, which was associated with the induction of Bcl-xL and inhibition of Bax, cleaved caspase 3, and cleaved PARP expression. Further studies revealed that CsA and FK506 inhibited PAN-induced p38 and JNK signaling, thereby protecting podocytes from PAN-induced injury. In conclusion, CsA and FK506 inhibit proteinuria by protecting against PAN-induced podocyte injury, which may be <jats:italic>associated with inhibition of the<\/jats:italic> MAPK signaling pathway.<\/jats:p>","DOI":"10.1038\/srep32087","type":"journal-article","created":{"date-parts":[[2016,9,1]],"date-time":"2016-09-01T10:53:28Z","timestamp":1472727208000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":70,"title":["Calcineurin inhibitors cyclosporin A and tacrolimus protect against podocyte injury induced by puromycin aminonucleoside in rodent models"],"prefix":"10.1038","volume":"6","author":[{"given":"Xiujin","family":"Shen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meike","family":"Ying","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhoutao","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiayu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haibing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuan","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yucheng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shi","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunhua","family":"Weng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiqiang","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huiping","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qin","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Bi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingyan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tongyu","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoru","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui-Yao","family":"Lan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianghua","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,9,1]]},"reference":[{"key":"BFsrep32087_CR1","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1038\/nrneph.2011.171","volume":"8","author":"PW Mathieson","year":"2011","unstructured":"Mathieson, P. W. The podocyte as a target for therapies\u2013new and old. NATURE REVIEWS NEPHROLOGY 8, 52\u201356 (2011).","journal-title":"NATURE REVIEWS NEPHROLOGY"},{"key":"BFsrep32087_CR2","doi-asserted-by":"crossref","unstructured":"Welsh G. I. & S. M. The podocyte cytoskeleton\u2013key to a functioning glomerulus in health and disease. Nat Rev Nephrol 8, 14\u201321 (2011).","DOI":"10.1038\/nrneph.2011.151"},{"key":"BFsrep32087_CR3","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1681\/asn.2012070734","volume":"24","author":"J Hogan","year":"2013","unstructured":"Hogan, J. & Radhakrishnan, J. The treatment of minimal change disease in adults. J Am Soc Nephrol 24, 702\u2013711, doi: 10.1681\/asn.2012070734 (2013).","journal-title":"J Am Soc Nephrol"},{"key":"BFsrep32087_CR4","doi-asserted-by":"publisher","first-page":"e106164","DOI":"10.1371\/journal.pone.0106164","volume":"9","author":"L Peng","year":"2014","unstructured":"Peng, L. et al. The calcineurin inhibitor tacrolimus reduces proteinuria in membranous nephropathy accompanied by a decrease in angiopoietin-like-4. PloS one 9, e106164, doi: 10.1371\/journal.pone.0106164 (2014).","journal-title":"PloS one"},{"key":"BFsrep32087_CR5","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.1007\/s00431-011-1397-6","volume":"170","author":"CJ Stefanidis","year":"2011","unstructured":"Stefanidis, C. J. & Querfeld, U. The podocyte as a target: cyclosporin A in the management of the nephrotic syndrome caused by WT1 mutations. Eur J Pediatr 170, 1377\u20131383, doi: 10.1007\/s00431-011-1397-6 (2011).","journal-title":"Eur J Pediatr"},{"key":"BFsrep32087_CR6","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1159\/000337175","volume":"35","author":"Q Zhang","year":"2012","unstructured":"Zhang, Q. et al. Tacrolimus improves the proteinuria remission in patients with refractory IgA nephropathy. Am J Nephrol 35, 312\u2013320 (2012).","journal-title":"Am J Nephrol"},{"key":"BFsrep32087_CR7","first-page":"711","volume":"18","author":"P Frassinetti Castelo Branco Camurca","year":"2005","unstructured":"Frassinetti Castelo Branco Camurca Fernandes, P. et al. Treatment of steroid-resistant nephrotic syndrome with cyclosporine: study of 17 cases and a literature review. J Nephrol 18, 711\u2013720 (2005).","journal-title":"J Nephrol"},{"key":"BFsrep32087_CR8","first-page":"33","volume":"96","author":"S Supavekin","year":"2013","unstructured":"Supavekin, S. et al. Tacrolimus in steroid resistant and steroid dependent childhood nephrotic syndrome. J Med Assoc Thai 96, 33\u201340 (2013).","journal-title":"J Med Assoc Thai"},{"key":"BFsrep32087_CR9","doi-asserted-by":"publisher","first-page":"2073","DOI":"10.1007\/s00467-012-2228-3","volume":"27","author":"W Wang","year":"2012","unstructured":"Wang, W. et al. Treatment of tacrolimus or cyclosporine A in children with idiopathic nephrotic syndrome. Pediatr Nephrol 27, 2073\u20132079, doi: 10.1007\/s00467-012-2228-3 (2012).","journal-title":"Pediatr Nephrol"},{"key":"BFsrep32087_CR10","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1053\/j.ajkd.2009.02.018","volume":"54","author":"X Li","year":"2009","unstructured":"Li, X. et al. Tacrolimus therapy in adults with steroid- and cyclophosphamide-resistant nephrotic syndrome and normal or mildly reduced GFR. Am J Kidney Dis 54, 51\u201358, doi: 10.1053\/j.ajkd.2009.02.018 (2009).","journal-title":"Am J Kidney Dis"},{"key":"BFsrep32087_CR11","doi-asserted-by":"publisher","first-page":"1919","DOI":"10.1093\/ndt\/gfm637","volume":"23","author":"X Li","year":"2008","unstructured":"Li X. et al. Tacrolimus as a steroid-sparing agent for adults with steroid-dependent minimal change nephrotic syndrome. Nephrol Dial Transplant 23, 1919\u20131925 (2008).","journal-title":"Nephrol Dial Transplant"},{"key":"BFsrep32087_CR12","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1038\/nm.1857","volume":"14","author":"C Faul","year":"2008","unstructured":"Faul C. et al. The actin cytoskeleton of kidney podocytes is a direct target of the antiproteinuric effect of cyclosporine A. Nat Med 14, 931\u2013938 (2008).","journal-title":"Nat Med"},{"key":"BFsrep32087_CR13","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1093\/ndt\/gfv015","volume":"30","author":"N Guan","year":"2015","unstructured":"Guan, N. et al. Protective role of cyclosporine A and minocycline on mitochondrial disequilibrium-related podocyte injury and proteinuria occurrence induced by adriamycin. Nephrol Dial Transplant 30, 957\u2013969, doi: 10.1093\/ndt\/gfv015 (2015).","journal-title":"Nephrol Dial Transplant"},{"key":"BFsrep32087_CR14","doi-asserted-by":"publisher","first-page":"1376","DOI":"10.1210\/me.2011-0029","volume":"25","author":"L Wang","year":"2011","unstructured":"Wang, L., Paik, C. J., Tang, S. Y., Eisner, Y., Spurney, W. & Calcineurin, R. F. (CN) activation promotes apoptosis of glomerular podocytes both in vitro and in vivo . Mol Endocrinol 25, 1376\u20131386 (2011).","journal-title":"Mol Endocrinol"},{"key":"BFsrep32087_CR15","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1016\/j.semnephrol.2012.06.011","volume":"32","author":"PL Tharaux","year":"2012","unstructured":"Tharaux, P. L. & Huber, T. B. How many ways can a podocyte die? Semin Nephrol 32, 394\u2013404, doi: 10.1016\/j.semnephrol.2012.06.011 (2012).","journal-title":"Semin Nephrol"},{"key":"BFsrep32087_CR16","doi-asserted-by":"publisher","first-page":"e27457","DOI":"10.1371\/journal.pone.0027457","volume":"6","author":"S Kummer","year":"2011","unstructured":"Kummer, S. et al. Estrogen receptor alpha expression in podocytes mediates protection against apoptosis in-vitro and in-vivo. PloS one 6, e27457, doi: 10.1371\/journal.pone.0027457 (2011).","journal-title":"PloS one"},{"key":"BFsrep32087_CR17","doi-asserted-by":"publisher","first-page":"2477","DOI":"10.1007\/s11033-009-9761-6","volume":"37","author":"S Liu","year":"2010","unstructured":"Liu, S., Ding, J., Fan, Q. & Zhang, H. The activation of extracellular signal-regulated kinase is responsible for podocyte injury. Molecular biology reports 37, 2477\u20132484, doi: 10.1007\/s11033-009-9761-6 (2010).","journal-title":"Molecular biology reports"},{"key":"BFsrep32087_CR18","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1159\/000355970","volume":"38","author":"Y Liu","year":"2013","unstructured":"Liu, Y. et al. IQGAP1 mediates angiotensin II-induced apoptosis of podocytes via the ERK1\/2 MAPK signaling pathway. Am J Nephrol 38, 430\u2013444, doi: 10.1159\/000355970 (2013).","journal-title":"Am J Nephrol"},{"key":"BFsrep32087_CR19","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.jbspin.2011.03.018","volume":"79","author":"JY Choe","year":"2012","unstructured":"Choe, J. Y., Lee, S. J., Park, S. H. & Kim, S. K. Tacrolimus (FK506) inhibits interleukin-1beta-induced angiopoietin-1, Tie-2 receptor, and vascular endothelial growth factor through down-regulation of JNK and p38 pathway in human rheumatoid fibroblast-like synoviocytes. Joint Bone Spine 79, 137\u2013143, doi: 10.1016\/j.jbspin.2011.03.018 (2012).","journal-title":"Joint Bone Spine"},{"key":"BFsrep32087_CR20","doi-asserted-by":"publisher","first-page":"2022","DOI":"10.1002\/ibd.21318","volume":"16","author":"T Yoshino","year":"2010","unstructured":"Yoshino, T. et al. Immunosuppressive effects of tacrolimus on macrophages ameliorate experimental colitis. Inflamm Bowel Dis 16, 2022\u20132033, doi: 10.1002\/ibd.21318 (2010).","journal-title":"Inflamm Bowel Dis"},{"key":"BFsrep32087_CR21","doi-asserted-by":"publisher","first-page":"e113520","DOI":"10.1371\/journal.pone.0113520","volume":"9","author":"YL Kang","year":"2014","unstructured":"Kang, Y. L., Saleem, M. A., Chan, K. W., Yung, B. Y. & Law, H. K. Trehalose, an mTOR independent autophagy inducer, alleviates human podocyte injury after puromycin aminonucleoside treatment. PloS one 9, e113520, doi: 10.1371\/journal.pone.0113520 (2014).","journal-title":"PloS one"},{"key":"BFsrep32087_CR22","doi-asserted-by":"publisher","first-page":"1232","DOI":"10.1038\/sj.ki.5002248","volume":"71","author":"T Kanjanabuch","year":"2007","unstructured":"Kanjanabuch, T. et al. PPAR-gamma agonist protects podocytes from injury. Kidney international 71, 1232\u20131239, doi: 10.1038\/sj.ki.5002248 (2007).","journal-title":"Kidney international"},{"key":"BFsrep32087_CR23","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1038\/sj.ki.5002362","volume":"72","author":"CM Logar","year":"2007","unstructured":"Logar, C. M., Brinkkoetter, P. T., Krofft, R. D., Pippin, J. W. & Shankland, S. J. Darbepoetin alfa protects podocytes from apoptosis in vitro and in vivo . Kidney international 72, 489\u2013498, doi: 10.1038\/sj.ki.5002362 (2007).","journal-title":"Kidney international"},{"key":"BFsrep32087_CR24","doi-asserted-by":"publisher","first-page":"2979","DOI":"10.1016\/j.cellsig.2014.08.030","volume":"26","author":"L Yu","year":"2014","unstructured":"Yu, L. et al. Smad3\/Nox4-mediated mitochondrial dysfunction plays a crucial role in puromycin aminonucleoside-induced podocyte damage. Cell Signal 26, 2979\u20132991, doi: 10.1016\/j.cellsig.2014.08.030 (2014).","journal-title":"Cell Signal"},{"key":"BFsrep32087_CR25","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1038\/ki.2009.424","volume":"77","author":"P Mundel","year":"2010","unstructured":"Mundel, P. & Reiser, J. Proteinuria: an enzymatic disease of the podocyte? Kidney international 77, 571\u2013580, doi: 10.1038\/ki.2009.424 (2010).","journal-title":"Kidney international"},{"key":"BFsrep32087_CR26","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1159\/000440851","volume":"42","author":"DS Dai","year":"2015","unstructured":"Dai, D. S. et al. Protective Effect of Salvia Przewalskii Extract on Puromycin-Induced Podocyte Injury. Am J Nephrol 42, 216\u2013227, doi: 10.1159\/000440851 (2015).","journal-title":"Am J Nephrol"},{"key":"BFsrep32087_CR27","doi-asserted-by":"publisher","first-page":"e0132724","DOI":"10.1371\/journal.pone.0132724","volume":"10","author":"R Liao","year":"2015","unstructured":"Liao, R. et al. Tacrolimus Protects Podocytes from Injury in Lupus Nephritis Partly by Stabilizing the Cytoskeleton and Inhibiting Podocyte Apoptosis. PloS one 10, e0132724, doi: 10.1371\/journal.pone.0132724 (2015).","journal-title":"PloS one"},{"key":"BFsrep32087_CR28","doi-asserted-by":"crossref","unstructured":"Wu, J. et al. MicroRNA-30 family members regulate calcium\/calcineurin signaling in podocytes. The Journal of clinical investigation, doi: 10.1172\/jci81061 (2015).","DOI":"10.1172\/JCI81061"},{"key":"BFsrep32087_CR29","doi-asserted-by":"publisher","first-page":"e0137049","DOI":"10.1371\/journal.pone.0137049","volume":"10","author":"JS Li","year":"2015","unstructured":"Li, J. S. et al. Angiopoietin-Like-4, a Potential Target of Tacrolimus, Predicts Earlier Podocyte Injury in Minimal Change Disease. PloS one 10, e0137049, doi: 10.1371\/journal.pone.0137049 (2015).","journal-title":"PloS one"},{"key":"BFsrep32087_CR30","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1053\/j.ajkd.2008.11.033","volume":"53","author":"S Choudhry","year":"2009","unstructured":"Choudhry, S. et al. Efficacy and safety of tacrolimus versus cyclosporine in children with steroid-resistant nephrotic syndrome: a randomized controlled trial. Am J Kidney Dis 53, 760\u2013769, doi: 10.1053\/j.ajkd.2008.11.033 (2009).","journal-title":"Am J Kidney Dis"},{"key":"BFsrep32087_CR31","doi-asserted-by":"publisher","first-page":"1913","DOI":"10.1172\/jci76767","volume":"125","author":"L Wang","year":"2015","unstructured":"Wang, L. et al. Gq signaling causes glomerular injury by activating TRPC6. The Journal of clinical investigation 125, 1913\u20131926, doi: 10.1172\/jci76767 (2015).","journal-title":"The Journal of clinical investigation"},{"key":"BFsrep32087_CR32","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1177\/1470320314568520","volume":"16","author":"Y Shengyou","year":"2015","unstructured":"Shengyou, Y., Li, Y., Zhihong, H. & Yuanyuan, M. Influence of tacrolimus on podocyte injury inducted by angiotensin II. Journal of the renin-angiotensin-aldosterone system: JRAAS 16, 260\u2013266, doi: 10.1177\/1470320314568520 (2015).","journal-title":"Journal of the renin-angiotensin-aldosterone system: JRAAS"},{"key":"BFsrep32087_CR33","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/s0002-9440(10)63966-1","volume":"158","author":"A Fornoni","year":"2001","unstructured":"Fornoni, A., Li, H., Foschi, A., Striker, G. E. & Striker, L. J. Hepatocyte growth factor, but not insulin-like growth factor I, protects podocytes against cyclosporin A-induced apoptosis. Am J Pathol 158, 275\u2013280, doi: 10.1016\/s0002-9440(10)63966-1 (2001).","journal-title":"Am J Pathol"},{"key":"BFsrep32087_CR34","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1093\/ndt\/gfq617","volume":"26","author":"E Schonenberger","year":"2011","unstructured":"Schonenberger, E., Ehrich, J. H., Haller, H. & Schiffer, M. The podocyte as a direct target of immunosuppressive agents. Nephrol Dial Transplant 26, 18\u201324, doi: 10.1093\/ndt\/gfq617 (2011).","journal-title":"Nephrol Dial Transplant"},{"key":"BFsrep32087_CR35","doi-asserted-by":"publisher","first-page":"1719","DOI":"10.1016\/j.ajpath.2011.06.033","volume":"179","author":"T Nijenhuis","year":"2011","unstructured":"Nijenhuis, T. et al. Angiotensin II contributes to podocyte injury by increasing TRPC6 expression via an NFAT-mediated positive feedback signaling pathway. Am J Pathol 179, 1719\u20131732 (2011).","journal-title":"Am J Pathol"},{"key":"BFsrep32087_CR36","doi-asserted-by":"publisher","first-page":"1657","DOI":"10.1681\/ASN.2009121253","volume":"21","author":"Y Wang","year":"2010","unstructured":"Wang, Y. et al. Activation of NFAT signaling in podocytes causes glomerulosclerosis. J Am Soc Nephrol. 21, 1657\u20131666 (2010).","journal-title":"J Am Soc Nephrol"},{"key":"BFsrep32087_CR37","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1007\/s00109-012-0960-6","volume":"90","author":"B Zhang","year":"2012","unstructured":"Zhang, B. et al. The calcineurin-NFAT pathway allows for urokinase receptor-mediated beta3 integrin signaling to cause podocyte injury. J Mol Med (Berl) 90, 1407\u20131420 (2012).","journal-title":"J Mol Med (Berl)"},{"key":"BFsrep32087_CR38","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1016\/j.bcp.2011.11.001","volume":"83","author":"S Akool el","year":"2012","unstructured":"Akool el, S. et al. Cyclosporin A and tacrolimus induce renal Erk1\/2 pathway via ROS-induced and metalloproteinase-dependent EGF-receptor signaling. Biochemical pharmacology 83, 286\u2013295, doi: 10.1016\/j.bcp.2011.11.001 (2012).","journal-title":"Biochemical pharmacology"},{"key":"BFsrep32087_CR39","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1093\/embo-reports\/kvd090","volume":"1","author":"S Matsuda","year":"2000","unstructured":"Matsuda, S. et al. Two distinct action mechanisms of immunophilin-ligand complexes for the blockade of T-cell activation. EMBO reports 1, 428\u2013434, doi: 10.1093\/embo-reports\/kvd090 (2000).","journal-title":"EMBO reports"},{"key":"BFsrep32087_CR40","doi-asserted-by":"publisher","first-page":"1358","DOI":"10.2174\/1568026033451916","volume":"3","author":"S Matsuda","year":"2003","unstructured":"Matsuda, S. & Koyasu, S. Regulation of MAPK signaling pathways through immunophilin-ligand complex. Current topics in medicinal chemistry 3, 1358\u20131367 (2003).","journal-title":"Current topics in medicinal chemistry"},{"key":"BFsrep32087_CR41","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1097\/01.tp.0000040002.12912.65","volume":"75","author":"CW Yang","year":"2003","unstructured":"Yang, C. W. et al. Preconditioning with cyclosporine A or FK506 differentially regulates mitogen-activated protein kinase expression in rat kidneys with ischemia\/reperfusion injury. Transplantation 75, 20\u201324, doi: 10.1097\/01.tp.0000040002.12912.65 (2003).","journal-title":"Transplantation"},{"key":"BFsrep32087_CR42","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1038\/ki.2008.559","volume":"75","author":"A Ijaz","year":"2009","unstructured":"Ijaz, A. et al. Inhibition of C-jun N-terminal kinase improves insulin sensitivity but worsens albuminuria in experimental diabetes. Kidney international 75, 381\u2013388, doi: 10.1038\/ki.2008.559 (2009).","journal-title":"Kidney international"},{"key":"BFsrep32087_CR43","doi-asserted-by":"publisher","first-page":"2690","DOI":"10.1681\/ASN.2004121084","volume":"16","author":"M Koshikawa","year":"2005","unstructured":"Koshikawa, M. et al. Role of p38 mitogen-activated protein kinase activation in podocyte injury and proteinuria in experimental nephrotic syndrome. J Am Soc Nephrol 16, 2690\u20132701, doi: 10.1681\/ASN.2004121084 (2005).","journal-title":"J Am Soc Nephrol"},{"key":"BFsrep32087_CR44","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1038\/ki.2008.203","volume":"74","author":"CX Zheng","year":"2008","unstructured":"Zheng, C. X. et al. Triptolide protects podocytes from puromycin aminonucleoside induced injury in vivo and in vitro . Kidney international 74, 596\u2013612, doi: 10.1038\/ki.2008.203 (2008).","journal-title":"Kidney international"},{"key":"BFsrep32087_CR45","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1038\/ki.2010.41","volume":"77","author":"ZH Chen","year":"2010","unstructured":"Chen, Z. H. et al. Triptolide reduces proteinuria in experimental membranous nephropathy and protects against C5b-9-induced podocyte injury in vitro . Kidney international 77, 974\u2013988, doi: 10.1038\/ki.2010.41 (2010).","journal-title":"Kidney international"},{"key":"BFsrep32087_CR46","doi-asserted-by":"publisher","first-page":"F509","DOI":"10.1152\/ajprenal.00661.2010","volume":"301","author":"R Pengal","year":"2011","unstructured":"Pengal, R. et al. Inhibition of the protein kinase MK-2 protects podocytes from nephrotic syndrome-related injury. Am J Physiol Renal Physiol 301, F509\u2013519, doi: 10.1152\/ajprenal.00661.2010 (2011).","journal-title":"Am J Physiol Renal Physiol"},{"key":"BFsrep32087_CR47","doi-asserted-by":"crossref","unstructured":"Hassan, H. et al. Essential Role of X-Box Binding Protein-1 during Endoplasmic Reticulum Stress in Podocytes. J Am Soc Nephrol, doi: 10.1681\/asn.2015020191 (2015).","DOI":"10.1681\/ASN.2015020191"},{"key":"BFsrep32087_CR48","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1093\/ndt\/gfu002","volume":"29","author":"Y Miyazaki","year":"2014","unstructured":"Miyazaki, Y. et al. Keap1 inhibition attenuates glomerulosclerosis. Nephrol Dial Transplant 29, 783\u2013791, doi: 10.1093\/ndt\/gfu002 (2014).","journal-title":"Nephrol Dial Transplant"},{"key":"BFsrep32087_CR49","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1681\/asn.2006060568","volume":"18","author":"A Doller","year":"2007","unstructured":"Doller, A. et al. Molecular mechanisms of cyclosporin A inhibition of the cytokine-induced matrix metalloproteinase-9 in glomerular mesangial cells. J Am Soc Nephrol 18, 581\u2013592, doi: 10.1681\/asn.2006060568 (2007).","journal-title":"J Am Soc Nephrol"},{"key":"BFsrep32087_CR50","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/S0014-2999(02)01587-X","volume":"443","author":"S Saito","year":"2002","unstructured":"Saito, S. et al. Cyclosporin A inhibits angiotensin II-induced c-Jun NH(2)-terminal kinase activation but not protein synthesis in vascular smooth muscle cells. Eur J Pharmacol 443, 47\u201350 (2002).","journal-title":"Eur J Pharmacol"},{"key":"BFsrep32087_CR51","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1159\/000331058","volume":"34","author":"AK Lim","year":"2011","unstructured":"Lim, A. K. et al. Evaluation of JNK blockade as an early intervention treatment for type 1 diabetic nephropathy in hypertensive rats. Am J Nephrol 34, 337\u2013346, doi: 10.1159\/000331058 (2011).","journal-title":"Am J Nephrol"},{"key":"BFsrep32087_CR52","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1016\/j.lab.2005.12.010","volume":"147","author":"CA Chen","year":"2006","unstructured":"Chen, C. A., Tsai, J. C., Su, P. W., Lai, Y. H. & Chen, H. C. Signaling and regulatory mechanisms of integrinalpha3beta1 on the apoptosis of cultured rat podocytes. The Journal of laboratory and clinical medicine 147, 274\u2013280, doi: 10.1016\/j.lab.2005.12.010 (2006).","journal-title":"The Journal of laboratory and clinical medicine"},{"key":"BFsrep32087_CR53","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1093\/toxsci\/kfr330","volume":"126","author":"S O\u2019Connell","year":"2012","unstructured":"O\u2019Connell, S., Tuite, N., Slattery, C., Ryan, M. P. & McMorrow, T. Cyclosporine A\u2013induced oxidative stress in human renal mesangial cells: a role for ERK 1\/2 MAPK signaling. Toxicological sciences: an official journal of the Society of Toxicology 126, 101\u2013113, doi: 10.1093\/toxsci\/kfr330 (2012).","journal-title":"Toxicological sciences: an official journal of the Society of Toxicology"},{"key":"BFsrep32087_CR54","doi-asserted-by":"publisher","first-page":"e8","DOI":"10.1159\/000131892","volume":"109","author":"T Wada","year":"2008","unstructured":"Wada, T., Pippin, J. W., Nangaku, M. & Shankland, S. J. Dexamethasone\u2019s prosurvival benefits in podocytes require extracellular signal-regulated kinase phosphorylation. Nephron. Experimental nephrology 109, e8\u201319, doi: 10.1159\/000131892 (2008).","journal-title":"Nephron. Experimental nephrology"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/srep32087.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep32087","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep32087.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,5]],"date-time":"2023-01-05T05:57:59Z","timestamp":1672898279000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/srep32087"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9,1]]},"references-count":54,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2016,9,30]]}},"alternative-id":["BFsrep32087"],"URL":"https:\/\/doi.org\/10.1038\/srep32087","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,9,1]]},"assertion":[{"value":"2 February 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 August 2016","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 September 2016","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"32087"}}